隆基绿能科技股份有限公司

Core Viewpoint - The company is optimizing the use of raised funds from convertible bonds to enhance operational efficiency and shareholder returns, while also addressing the challenges posed by the photovoltaic industry's cyclical nature and price fluctuations [1][27][34]. Fund Utilization - The company has permanently supplemented its working capital with a total of 43.22 million yuan from surplus funds raised through the 2019 convertible bonds, including 18.34 million yuan from the completed Jiaxing photovoltaic project [1]. - The company has also approved the use of 49.65 million yuan from surplus funds of the Xixian Leafe 29GW high-efficiency monocrystalline battery project to permanently supplement working capital [5]. - As of June 14, 2023, the company returned 3.5 billion yuan of temporarily supplemented working capital back to the dedicated fund account [4]. Project Adjustments - The company has decided to postpone the Wuhu (Phase II) 15GW monocrystalline component project to June 2026 due to the cyclical supply-demand mismatch in the photovoltaic industry [6][27]. - The implementation subject of the 5GW monocrystalline battery project has been changed to include the company’s wholly-owned subsidiary, Longi Leafe, and Ningxia Longi Photovoltaic Technology Co., Ltd. [11][12]. Financial Performance - The company reported significant losses in 2024, with the Xixian Leafe 29GW battery project realizing a loss of 82.06 million yuan, attributed to price declines in the photovoltaic industry and temporary shutdowns for technological upgrades [28]. - The Jiaxing photovoltaic project and the Ningxia Leafe 5GW battery project also reported losses of 23.87 million yuan and 25.91 million yuan, respectively, due to similar industry challenges [22][23]. Governance and Compliance - The company has adhered to relevant laws and regulations regarding the management and use of raised funds, with no violations reported [14]. - The company has received positive evaluations from its sponsor regarding the management of raised funds, confirming compliance with regulatory requirements [14].